Life Sciences Report

Biobased polymers are a class of polymers that are manufactured from a biomass source, rather than from an oleochemical source. Although some of these types of polymers have been well known for over a century, they have not yet seen widespread application due to barriers facing production, such as cost and scale. However, thanks to innovations in synthetic biology, these polymers are becoming more affordable to manufacture, and therefore more commonly encountered. Increasing customer awareness of the climate impact of petrochemically derived polymers as well as a global shift in demand away from plastics with a lifespan of several hundreds of years has resulted in renewed focus on this previously inaccessible area. Biobased polymers can come in multiple different forms: direct, or "drop-in" replacements for their petrochemical counterparts offering near-identical properties, or entirely novel polymers that were previously inaccessible, such as polylactide, some of which offer substantially improved technical specifications compared to their alternatives.

 

In 2018, the range of biobased polymers is hugely varied, yet disparate. Biobased Polymers 2018: A Technology and Market Perspective takes an in-depth look into the diverse range of biobased polymers, from established to nascent, providing detailed case studies of leading edge companies developing the technology, while pulling together related polymer classes. An overview of the latest tools utilised in the field of synthetic biology is provided, with focus on CRISPR, protein and organism engineering and commercial scale fermentation. Furthermore, this report cuts through the marketing hype to offer a detailed insight into some of the foremost biobased polymer companies leading global innovation and bringing potentially disruptive products to market.

 

This report provides an overview of the technological advancements in biobased polymers to date, a comprehensive insight into the drivers and restraints affecting synthesis and production at scale for all key application areas discussed and provides case studies and SWOT analyses for the most prolific disrupters developing biobased polymers. IDTechEx conducted exhaustive primary research with companies across a range of industries developing synthetic biology for key insights into the drivers and restraints affecting the growth of this technology.

 

 

 

This report is relevant to venture capitalists and private equity firms looking to invest in the latest synthetic biology start-up, several of which have been interviewed for this report.

 

Product manufacturers in the fast moving consumer goods industry, food and beverage industries, medical and pharmaceutical industries investigating how their products may be disrupted by synthetic biology or identifying potential collaborators/acquisition targets/competitors will also stand to benefit from purchasing this report.

All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

If you have any questions about this report, please do not hesitate to contact our report team at research@IDTechEx.com or call one of our sales managers:

Americas: +1 617 577 7890
Europe: +44 1223 812300
China: +86 158 5036 8392
Korea: +82 2 552 5567
Taiwan: +886 (0)9 3999 9792
Rest of Asia: +81 90 1704 1184